aTYR PHARMA INC
ATYR· Nasdaq
ATYRaTYR PHARMA INC
Filed Mar 15, 2022 · 10-K · 74 days after period end · 0001564590-22-010441
derived · Computed from the longer spans the company filed.
| Metric | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019 | Q4 2018 |
|---|---|---|---|---|
| Revenue | — | $2.05M | — | — |
| Net Income | -$8.56M | -$4.93M | -$5.97M | -$6.32M |
| EPS Diluted | — | — | -$1.54 | -$2.92 |
aTYR PHARMA INC · CIK 1339970 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2021 · filed Mar 15, 2022 · 74 d after period end
